TrialCell2020
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
Yapeng Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
407 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialCell2020
Yapeng Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.